Webdisclosure.com

Search

INVENTIVA (EPA:IVA) Inventiva reports its 2021 Full-Year Results: key milestones achieved with lanifibranor in NASH and cedirogant in psoriasis

Directive transparence : information réglementée

07/03/2022 22:26